Benzinga | Aug 3, 2021 04:30PM EDT

Aptose Biosciences Q2 EPS $(0.15) Misses $(0.14) Estimate

Aptose Biosciences (NASDAQ:APTO) reported quarterly losses of $(0.15) per share which missed the analyst consensus estimate of $(0.14) by 7.14 percent. This is a 28.57 percent increase over losses of $(0.21) per share from the same period last year.